Stock P09 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Pacific Biosciences of California, Inc. BOERSE MUENCHEN

Equities

P09

US69404D1081

Real-time BOERSE MUENCHEN
Other stock markets
 09:23:36 2024-07-03 EDT 		5-day change 1st Jan Change
1.193 EUR +1.32% Intraday chart for Pacific Biosciences of California, Inc. -9.97% -87.43%
07-01 Pacific Biosciences of California, Inc.(NasdaqGS:PACB) dropped from Russell 2500 Growth Index CI
06-27 PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
PacBio, Form Bio Team Up to Launch Initiatives to Unify AAV Gene Therapy Industry
Form Bio and Pacbio Announce Collaboration to Launch New Resources Set to Transform Aav Design and Analysis Best Practices
PacBio and International Research Consortium Colors Announce Release of First-Ever HiFi Long-Read Variant Database
Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes
Ambry Genetics and PacBio Announces Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
Pacific Biosciences of California, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Pacific Biosciences of California, Inc Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
PacBio Announces New Nanobind Pandna Kit Enabling Hifi Optimized Dna Extraction Solutions
Pacific Biosciences Posts Higher Preliminary Q4, Full-Year 2023 Revenue
Pacific Biosciences of California, Inc. Announces Resignation of David Botstein from the Board
Pacific Biosciences of California Shares Rise After UBS Upgrade
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
Pacific Biosciences of California Teams Up With Geneyx, Golden Helix in Disease Research
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PACB Stock
  4. P09 Stock
  5. News Pacific Biosciences of California, Inc.
  6. Other languages